Predicate |
Object |
contentType |
Journal Article|Retraction of Publication |
issn |
0753-3322 |
pageRange |
112854- |
publicationName |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
startingPage |
112854 |
bibliographicCitation |
Gao W, Ge S, Sun J. Retraction notice to \"Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion\" [Biomed. Pharmacother. 109 (2019) 1062-1069]. Biomed Pharmacother. 2022 Jun;150():112854. doi: 10.1016/j.biopha.2022.112854. PMID: 35341636. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15ca89b1cd4bb74a14ce626347786c0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b5d770129a586b4519f582f4224151f |
date |
202206 |
identifier |
https://doi.org/10.1016/j.biopha.2022.112854 https://pubmed.ncbi.nlm.nih.gov/35341636 |
isPartOf |
https://portal.issn.org/resource/ISSN/0753-3322 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1156 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Retraction notice to “Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion” [Biomed. Pharmacother. 109 (2019) 1062–1069] |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49798941 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146160313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102004514 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280688 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90477939 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15558545 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72965 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129316867 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |